Home Startup news Alphabet's life sciences arm Verily raises $1bn from investors

Alphabet’s life sciences arm Verily raises $1bn from investors

Follow us

Udit Agarwal
Startup/Tech News Correspondent, Responsible for gathering information on the tech companies working on IOT, AI, ML, Cloud, Mobile Technologies, Udit can be reached at [email protected]

Article Crux

  • Verily, the Alphabet Inc life science division, yesterday revealed a $1 Billion investment round which is led by the private equity firm Silver Lake.
  • Alphabet Chief Financial Officer Ruth Porat and Silver Lake Managing Director Egon Durban will be going to be nominated to Verify

Alphabet life science company has now tied up with the several pharma companies on the projects that mainly range from the research on the surgical robots to developing the retina scan technology for the early detection of some of the eye diseases.

Verily, the Alphabet Inc life science division, yesterday revealed a $1 Billion investment round which is led by the private equity firm Silver Lake. Alphabet Chief Financial Officer Ruth Porat and Silver Lake Managing Director Egon Durban will be going to be nominated to Verify’s operating board, according to the company.

Verily, which was also previously a part of the Google Research and Development unit, received an $800 Million Investment from the Singapore state investors Temasek in the year 2017. Verily said that the new funds would now going to support its investment, which includes potential partnerships and acquisitions, and would soon also going to advance its strategies that are complementary to its current portfolio.

The company has now also tied up with the several pharma companies on the projects that range from the research on the surgical robots to developing the retina scan technology for the early detection of some of the eye diseases. Verily as of now did not close the financial terms and conditions of the latest investment round into the report. Goldman Sachs and Co LLC also acted as a financial advisor to the company.

“We are taking external funding to increase flexibility and optionality as we expand on our core strategic focus areas,” said Andrew Conrad, chief executive of Verily. “Adding a well-rounded group of seasoned investors, led by Silver Lake, will further prepare us to execute as healthcare continues the shift towards evidence generation and value-based reimbursement models.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Stories

Eros Now announces a collaboration with Microsoft

Eros Now announces a collaboration with Microsoft to develop the next-generation online video platform

How IoT Healthcare Solutions are creating a Healthcare Revolution

Technology continues to amaze many by introducing effective solutions that otherwise seem impossible. One of the things...

How to Maintain a Home Security Camera

One of the reasons for purchasing a home security camera is to keep your property, possessions, and loved ones...

Cybereye to organise Asia’s largest conference in LoRaWAN

From smart agriculture to smart cities, Internet of Things has applications in every vertical. This revolutionary technology...

How Machine Learning Solutions Can Help Small And Medium Businesses

The field of machine learning analytics has completely transformed the traditional computing as machines are now capacitated...

8 Common Influencer Marketing Pitfalls, How to Avoid Them

Influencer marketing is the word marketing on steroids of yesterday. The web makes it possible for people just like...

IoT For Agriculture Shaping The Future Of Farming, India To Witness Remarkable Growth

It is no secret that the Internet of Things (IoT) is conquering every sector in its path....

More Articles Like This

Popular This week

Join our list

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

Join our list

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.

Join our list

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.